Article
Expression of Elafin and CD200 as Immune Checkpoint Molecules Involved in Celiac Disease.
International journal of molecular sciences - 10 Jan 2024
Ponce-de-León Candelaria, Lorite Pedro, López-Casado Miguel Ángel, Mora Pablo, Palomeque Teresa, Torres María Isabel
Abstract excerpt
We comprehensively evaluated the expression of therapeutically targetable immune checkpoint molecules involved in celiac disease (CD). We have focused on the alteration of the CD200/CD200R pathway and Elafin expression in celiac disease and discussed their roles in regulating the immune response. There are limited data related to the expression or function of these molecules in celiac disease. This finding could...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
